MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Home・Akcijų sąrašas・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

27.74 -0.72

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

27.54

Max

27.82

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-28M 22M
Pardavimai	4.3M 244M
P/E Sektoriaus vid.	9.926 56.063
Pelno marža	9.224
Darbuotojai	293
EBITDA	-22M 52M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+47.53% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-05

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	8.3M 1.6B
Ankstesnė atidarymo kaina	28.46
Ankstesnė uždarymo kaina	27.74

Naujienos nuotaikos

By Acuity

72%

28%

324 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

29.8 / N/A Palaikymas ir pasipriešinimas

Harmony Biosciences Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-02 17:11; UTC

Pagrindinės rinkos jėgos

Svarbiausios naujienos

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2026-04-02 17:10; UTC

Svarbiausios naujienos

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

2026-04-03 00:00; UTC

Svarbiausios naujienos

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2026-04-02 23:47; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2026-04-02 21:05; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2026-04-02 21:05; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2026-04-02 21:05; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2026-04-02 21:05; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2026-04-02 21:01; UTC

Svarbiausios naujienos

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2026-04-02 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks and Boyu Capital Finalize China JV

2026-04-02 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-04-02 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-04-02 20:41; UTC

Uždarbis

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2026-04-02 20:32; UTC

Rinkos pokalbiai

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2026-04-02 20:30; UTC

Įsigijimai, susijungimai, perėmimai

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2026-04-02 20:09; UTC

Rinkos pokalbiai

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2026-04-02 20:01; UTC

Įsigijimai, susijungimai, perėmimai

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2026-04-02 19:46; UTC

Rinkos pokalbiai

Is Oil the New GameStop? -- Market Talk

2026-04-02 19:35; UTC

Rinkos pokalbiai

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2026-04-02 19:29; UTC

Įsigijimai, susijungimai, perėmimai

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2026-04-02 19:24; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2026-04-02 19:20; UTC

Rinkos pokalbiai

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2026-04-02 19:01; UTC

Įsigijimai, susijungimai, perėmimai

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2026-04-02 19:00; UTC

Įsigijimai, susijungimai, perėmimai

Union Pacific: Agreement Reached With American Train Dispatchers Association

2026-04-02 18:24; UTC

Įsigijimai, susijungimai, perėmimai

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2026-04-02 17:44; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2026-04-02 17:32; UTC

Svarbiausios naujienos

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2026-04-02 17:26; UTC

Uždarbis

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2026-04-02 17:17; UTC

Rinkos pokalbiai

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2026-04-02 17:09; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Akcijų palyginimas

Kainos pokytis

Harmony Biosciences Holdings Inc Prognozė

Kainos tikslas

By TipRanks

47.53% į viršų

12 mėnesių prognozė

Vidutinis 41.25 USD 47.53%

Aukščiausias 62 USD

Žemiausias 25 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Harmony Biosciences Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

8 ratings

Pirkti

Laikyti

Parduoti

Remiantis 8 analitikų, pateikusių Harmony Biosciences Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

29.8 / N/APalaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

324 / 349 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.